ArticleEuropean journal of pain (London, England)2026
A 5-Item Prediction Model Incorporating Pain With Neuropathic Characteristics at 2 Weeks for Chronic Postsurgical Pain After Video-Assisted Thoracoscopic Lung Surgery: A Prospective Cohort Study.
Article in European journal of pain (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic postsurgical pain (CPSP) after video-assisted thoracoscopic surgery (VATS) is common, yet clinicians lack tools to identify high-risk patients at routine follow-up. We hypothesized that pain with neuropathic characteristics at 2 weeks, signifying central sensitization, could stratify risk and guide precision analgesia.
methodsThis prospective cohort study enrolled 500 adults undergoing VATS lung resection. Two logistic models were developed: one using variables on postoperative day 1 (POD1), and another adding neuropathic pain features on POD14. The primary outcome was CPSP at 3 months, defined as a Numerical Rating Scale [NRS] score ≥ 1 for pain in the surgical region that was not present preoperatively and was not attributable to malignancy or infection; sensitivity analysis was conducted using NRS ≥ 3. Discrimination (area under the curve [AUC]), calibration and decision curve analysis quantified predictive performance and potential clinical applicability.
resultsOf 483 patients analysed, 247 (51.1%) developed CPSP and 184 (38.1%) had 3-mon NRS ≥ 3. The POD14 model (sex, surgery type, chest tube duration, pain intensity, pain with neuropathic characteristics) was superior (AUC 0.904, 95% CI: 0.872-0.936) to the POD1 model (AUC 0.865, 95% CI: 0.827-0.903). Neuropathic pain at 2 weeks was the strongest predictor (odds ratio 13.98, 95% CI: 2.90-67.38). Temporal validation confirmed discrimination with good calibration. Sensitivity analysis showed an AUC of 0.786 (95% CI: 0.737-0.835) for the POD14 model; pain with neuropathic characteristics retained strong predictive value.
conclusionsThis 5-item tool with neuropathic pain features at 2-week visit identifies patients at high risk for CPSP after VATS. SIGNIFICANCE STATEMENT: Translating central sensitization from a theoretical mechanism to an actionable bedside tool, this study demonstrates that neuropathic pain features captured at routine two-week follow-up stratify risk for CPSP after VATS. This 5-item model is a first step toward individualized CPSP risk stratification after VATS and requires external validation before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.